Atatürk Üniversitesi Atatürk Üniversitesi
Ara
Yayınlara dön
Makale Kısa Makale Uluslararası 2024

Pembrolizumab in HER2-Positive Gastric Cancer

Yelena Y. Janjigian, Akihito Kawazoe, Yuxian Bai, Jianming Xu, Sara Lonardi, Jean Phillipe Metges, Patricio Yanez, Lucjan S. Wyrwicz, Lin Shen, Yuriy Ostapenko, Mehmet Bilici, Hyun Cheol Chung, Kohei Shitara, Shukui Qin, Eric Van Cutsem, Josep Tabernero, Suxia Luo, Mauricio Mahave, Yong Tang, Maeve Lowery, Maria M. F. Monteiro, Linzhi Xu, Chie-Schin Shih, Kanu P. Sharan, Pooja Bhagia, Sun Young Rha

NEW ENGLAND JOURNAL OF MEDICINE 01.09.2024
DOI ile aç

Özet

Pembrolizumab in HER2-Positive Gastric Cancer The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone.

Atıf için künye

Janjigian, Y. Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J. P., Yanez, P., Wyrwicz, L. S., Shen, L., Ostapenko, Y., Bilici, M., Chung, H. C., Shitara, K., Qin, S., Van Cutsem, E., Tabernero, J., Luo, S., Mahave, M., Tang, Y., … Rha, S. Y. (2024). Pembrolizumab in HER2-Positive Gastric Cancer. NEW ENGLAND JOURNAL OF MEDICINE. https://doi.org/10.1056/nejmc2408121

BibTeX
@article{janjigian2024-228388,
  author = {Janjigian, Yelena Y. and Kawazoe, Akihito and Bai, Yuxian and Xu, Jianming and Lonardi, Sara and Metges, Jean Phillipe and Yanez, Patricio and Wyrwicz, Lucjan S. and Shen, Lin and Ostapenko, Yuriy and Bilici, Mehmet and Chung, Hyun Cheol and Shitara, Kohei and Qin, Shukui and Van Cutsem, Eric and Tabernero, Josep and Luo, Suxia and Mahave, Mauricio and Tang, Yong and Lowery, Maeve and Monteiro, Maria M. F. and Xu, Linzhi and Shih, Chie-Schin and Sharan, Kanu P. and Bhagia, Pooja and Rha, Sun Young},
  title = {Pembrolizumab in HER2-Positive Gastric Cancer},
  journal = {NEW ENGLAND JOURNAL OF MEDICINE},
  year = {2024},
  issn = {0028-4793},
  doi = {10.1056/nejmc2408121},
  url = {https://akademik.atauni.edu.tr/yayinlar/228388-pembrolizumab-in-her2-positive-gastric-cancer}
}